Constructive news tone
News Sentiment
GRCL sentiment intelligence
Gracell Biotechnologies Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
68
Constructive news tone
31 relevant articles
News tone and price action are not far from neutral.
72/100 classification confidence.
directly relevant articles
high-authority source matches
+0.0% over one week, +0.0% over four weeks, trend active, and materially above fair value.
Gracell Biotechnologies Inc. v. Alpine Global Management LLC: Discovery Application (Cayman Islands)
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
72/100 classification
One-week reaction
0.0%
Price digesting
Trend fit
Trend active
0.0% over four weeks
Fair value
81.9%
Materially above fair value
Sentiment confirms active trend
Positive but stretched
Sentiment Mix
Positive, neutral, negative
Positive
18
Neutral
11
Negative
2
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
BioSpace
Direct company coverage
Gracell Biotechnologies Raises $100 Million in Series C Funding to Advance Next Generation CAR-T Cell Therapies
Gracell Biotechnologies, a clinical-stage biopharmaceutical company, announced it has secured $100 million in Series C funding led by Wellington Management Company, OrbiMed, and Morningside Ventures. The funding will advance the company's next-generation CAR-T cell therapies whic
- Tone
- Positive 92/100
- Event
- Market update
- Published
- 28 Oct 2020 08:09
- Source
- BioSpace